COVID-19: WHO recommends Merck pill for non-severe, at-risk patients

The World Health Organization on Wednesday recommended an anti-COVID pill be taken by sufferers who have mild symptoms but are at high risk of hospitalisation, such as older people or the unvaccinated. The pill, called molnupiravir and developed by US pharmaceutical Merck, is taken as soon as possible after COVID-19 symptoms develop and then for…

Read More

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: